Showing 1 - 2 results of 2 for search 'Jianhong Zhong', query time: 0.01s
Refine Results
-
1
-
2
First-line tislelizumab and ociperlimab combined with gemcitabine and cisplatin in advanced biliary tract cancer (ZSAB-TOP): a multicenter, single-arm, phase 2 study by Guoming Shi, Xiaoyong Huang, Liang Ma, Hui Li, Jianhong Zhong, Junye Wang, Qiang Gao, Xiaojun Guo, Shuangjian Qiu, Huichuan Sun, Yinghong Shi, Xiaowu Huang, Xiaoying Wang, Yong Yi, Xiaodong Zhu, Cheng Huang, Zhenbin Ding, Yi Chen, Yifeng He, Yinghao Shen, Qiman Sun, Jian Zhou, Jia Fan
Published 2025-08-01Get full text
Article